226 related articles for article (PubMed ID: 32473963)
41. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
[TBL] [Abstract][Full Text] [Related]
42. Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy.
Coats CJ; Gallagher MJ; Foley M; O'Mahony C; Critoph C; Gimeno J; Dawnay A; McKenna WJ; Elliott PM
Eur Heart J; 2013 Aug; 34(32):2529-37. PubMed ID: 23455360
[TBL] [Abstract][Full Text] [Related]
43. N-terminal pro-brain natriuretic peptide predicts hospitalization for ischemic stroke in Japanese hemodialysis patients.
Yamaoka M; Yoshida M; Nakashima A; Doi S; Naito T; Masaki T
Clin Exp Nephrol; 2022 Nov; 26(11):1111-1118. PubMed ID: 35838853
[TBL] [Abstract][Full Text] [Related]
44. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.
Eren NK; Ertaş F; Yüksek U; Cakir C; Nazli C; Köseoğlu M; Ergene O
Turk Kardiyol Dern Ars; 2009 Jan; 37(1):1-8. PubMed ID: 19225247
[TBL] [Abstract][Full Text] [Related]
45. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A
Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781
[TBL] [Abstract][Full Text] [Related]
46. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
[TBL] [Abstract][Full Text] [Related]
48. NT-proBNP predicts mortality in adults with transposition of the great arteries late after Mustard or Senning correction.
Popelová JR; Tomková M; Tomek J
Congenit Heart Dis; 2017 Jul; 12(4):448-457. PubMed ID: 28419713
[TBL] [Abstract][Full Text] [Related]
49. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
[TBL] [Abstract][Full Text] [Related]
50. Prognostic value of plasma N-terminal pro B-type natriuretic peptide levels in pneumonia patients requiring intensive care unit admission.
Lin SC; Tsai YJ; Huang CT; Kuo YW; Ruan SY; Chuang YC; Yu CJ
Respirology; 2013 Aug; 18(6):933-41. PubMed ID: 23600467
[TBL] [Abstract][Full Text] [Related]
51. Prognostic Value of B-Type Natriuretic Peptide, Leukocytosis, and Hyperglycemia in Children with Severe Hand, Foot, and Mouth Disease.
Lee CC; Lu X; Xiao Z; Yang M; Zhu Y
Shock; 2016 Jun; 45(6):620-5. PubMed ID: 26717102
[TBL] [Abstract][Full Text] [Related]
52. A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes.
Ndrepepa G; Braun S; Mehilli J; Niemöller K; Schömig A; Kastrati A
Clin Res Cardiol; 2007 Jan; 96(1):30-7. PubMed ID: 17066344
[TBL] [Abstract][Full Text] [Related]
53. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
54. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism.
Lankeit M; Jiménez D; Kostrubiec M; Dellas C; Kuhnert K; Hasenfuß G; Pruszczyk P; Konstantinides S
Eur Respir J; 2014 Jun; 43(6):1669-77. PubMed ID: 24627529
[TBL] [Abstract][Full Text] [Related]
55. Relationship of Red Cell Volume Distribution Width and N-Terminal Pro-Brain Natriuretic Peptide with Severity and Prognosis of Patients with Acute Coronary Syndrome Receiving Percutaneous Coronary Intervention.
Pan R
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255302
[TBL] [Abstract][Full Text] [Related]
56. Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients.
Eriguchi M; Tsuruya K; Lopes M; Bieber B; McCullough K; Pecoits-Filho R; Robinson B; Pisoni R; Kanda E; Iseki K; Hirakata H
ESC Heart Fail; 2022 Apr; 9(2):1138-1151. PubMed ID: 35026869
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis.
Farré N; Gómez M; Molina L; Cladellas M; Blé M; Roqueta C; Ascoeta MS; Comin-Colet J; Vila J; Bruguera J
Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):52-7. PubMed ID: 24774264
[TBL] [Abstract][Full Text] [Related]
58. Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure.
Yoon JY; Yang DH; Cho HJ; Kim NK; Kim CY; Son J; Roh JH; Jang SY; Bae MH; Lee JH; Park HS; Cho Y; Chae SC
Korean J Intern Med; 2019 Jul; 34(4):811-818. PubMed ID: 30616330
[TBL] [Abstract][Full Text] [Related]
59. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
60. Renal dysfunction and accuracy of N-terminal pro-B-type natriuretic peptide in predicting mortality for hospitalized patients with heart failure.
Scrutinio D; Mastropasqua F; Guida P; Ammirati E; Ricci V; Raimondo R; Frigerio M; Lagioia R; Oliva F
Circ J; 2014; 78(10):2439-46. PubMed ID: 25168191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
